La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.

Identifieur interne : 001244 ( Main/Exploration ); précédent : 001243; suivant : 001245

Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.

Auteurs : Moonhee Lee ; Byoung-Mog Kwon ; Byoung-Mok Kwon ; Kyoungho Suk ; Edith Mcgeer ; Patrick L. Mcgeer

Source :

RBID : pubmed:21796424

English descriptors

Abstract

Earlier studies indicate that obovatol (OBO), isolated from a medicinal herb Magnolia obovata, has anti-inflammatory and anti-oxidative properties. Depletion of glutathione (GSH) in glial cells with the γ-glutamylcysteine synthase inhibitor D,L-buthionine-S,R-sulfoximine (BSO) is known to produce oxidative stress which, in turn, induces these cells to secrete inflammatory cytokines and other neurotoxic substances. In the present study, we investigated the ability of OBO to protect SH-SY5Y neuroblastoma cells from this effect. Human microglia, astrocytes and their surrogate THP-1 and U373 cell lines were activated by treatment with BSO. Such treatment depleted their intracellular GSH and increased levels of damage to DNA, lipids and proteins (8-OHdG, lipid peroxide, protein carbonyls and 3-nitrotyrosine), and activated the inflammatory pathways P38 MAP kinase and NFκB. These are accompanied by release of proinflammatory factors such as TNFα, IL-6 and nitric oxide. Their conditioned media were toxic to SH-SY5Y cells. All these effects were attenuated by pre-treatment with OBO. Prior treatment of SH-SY5Y cells with OBO also attenuated THP-1 or U373 conditioned media neurotoxicity and also reduced oxidative damage produced by treatment with hydrogen peroxide or BSO. Prior treatment with OBO potentiated survival of SH-SY5Y cells exposed to conditioned medium from BSO-treated THP-1, U373 cells, microglia and astrocytes. The data indicate that OBO could be anti-inflammatory, anti-oxidative and neuroprotective, and be an effective agent for inhibiting pathogenesis in neurological diseases such as Alzheimer disease, Parkinson disease and amyotrophic lateral sclerosis in which glial-mediated neuroinflammation and oxidative stress are thought to contribute to disease progression.

DOI: 10.1007/s11481-011-9300-9
PubMed: 21796424


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.</title>
<author>
<name sortKey="Lee, Moonhee" sort="Lee, Moonhee" uniqKey="Lee M" first="Moonhee" last="Lee">Moonhee Lee</name>
<affiliation>
<nlm:affiliation>Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z3.</nlm:affiliation>
<wicri:noCountry code="subField">V6T 1Z3</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kwon, Byoung Mog" sort="Kwon, Byoung Mog" uniqKey="Kwon B" first="Byoung-Mog" last="Kwon">Byoung-Mog Kwon</name>
</author>
<author>
<name sortKey="Kwon, Byoung Mok" sort="Kwon, Byoung Mok" uniqKey="Kwon B" first="Byoung-Mok" last="Kwon">Byoung-Mok Kwon</name>
</author>
<author>
<name sortKey="Suk, Kyoungho" sort="Suk, Kyoungho" uniqKey="Suk K" first="Kyoungho" last="Suk">Kyoungho Suk</name>
</author>
<author>
<name sortKey="Mcgeer, Edith" sort="Mcgeer, Edith" uniqKey="Mcgeer E" first="Edith" last="Mcgeer">Edith Mcgeer</name>
</author>
<author>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:21796424</idno>
<idno type="pmid">21796424</idno>
<idno type="doi">10.1007/s11481-011-9300-9</idno>
<idno type="wicri:Area/PubMed/Corpus">000A97</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A97</idno>
<idno type="wicri:Area/PubMed/Curation">000A97</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A97</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A97</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A97</idno>
<idno type="wicri:Area/Ncbi/Merge">000F33</idno>
<idno type="wicri:Area/Ncbi/Curation">000F33</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000F33</idno>
<idno type="wicri:Area/Main/Merge">001270</idno>
<idno type="wicri:Area/Main/Curation">001244</idno>
<idno type="wicri:Area/Main/Exploration">001244</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.</title>
<author>
<name sortKey="Lee, Moonhee" sort="Lee, Moonhee" uniqKey="Lee M" first="Moonhee" last="Lee">Moonhee Lee</name>
<affiliation>
<nlm:affiliation>Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z3.</nlm:affiliation>
<wicri:noCountry code="subField">V6T 1Z3</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kwon, Byoung Mog" sort="Kwon, Byoung Mog" uniqKey="Kwon B" first="Byoung-Mog" last="Kwon">Byoung-Mog Kwon</name>
</author>
<author>
<name sortKey="Kwon, Byoung Mok" sort="Kwon, Byoung Mok" uniqKey="Kwon B" first="Byoung-Mok" last="Kwon">Byoung-Mok Kwon</name>
</author>
<author>
<name sortKey="Suk, Kyoungho" sort="Suk, Kyoungho" uniqKey="Suk K" first="Kyoungho" last="Suk">Kyoungho Suk</name>
</author>
<author>
<name sortKey="Mcgeer, Edith" sort="Mcgeer, Edith" uniqKey="Mcgeer E" first="Edith" last="Mcgeer">Edith Mcgeer</name>
</author>
<author>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</analytic>
<series>
<title level="j">Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</title>
<idno type="eISSN">1557-1904</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anti-Inflammatory Agents (pharmacology)</term>
<term>Antioxidants (pharmacology)</term>
<term>Biphenyl Compounds (pharmacology)</term>
<term>Cell Line</term>
<term>Glutathione (metabolism)</term>
<term>Humans</term>
<term>Inflammation (prevention & control)</term>
<term>Neuroglia (drug effects)</term>
<term>Neuroprotective Agents (pharmacology)</term>
<term>Oxidative Stress (drug effects)</term>
<term>Phenyl Ethers (pharmacology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Glutathione</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Inflammatory Agents</term>
<term>Antioxidants</term>
<term>Biphenyl Compounds</term>
<term>Neuroprotective Agents</term>
<term>Phenyl Ethers</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Neuroglia</term>
<term>Oxidative Stress</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Earlier studies indicate that obovatol (OBO), isolated from a medicinal herb Magnolia obovata, has anti-inflammatory and anti-oxidative properties. Depletion of glutathione (GSH) in glial cells with the γ-glutamylcysteine synthase inhibitor D,L-buthionine-S,R-sulfoximine (BSO) is known to produce oxidative stress which, in turn, induces these cells to secrete inflammatory cytokines and other neurotoxic substances. In the present study, we investigated the ability of OBO to protect SH-SY5Y neuroblastoma cells from this effect. Human microglia, astrocytes and their surrogate THP-1 and U373 cell lines were activated by treatment with BSO. Such treatment depleted their intracellular GSH and increased levels of damage to DNA, lipids and proteins (8-OHdG, lipid peroxide, protein carbonyls and 3-nitrotyrosine), and activated the inflammatory pathways P38 MAP kinase and NFκB. These are accompanied by release of proinflammatory factors such as TNFα, IL-6 and nitric oxide. Their conditioned media were toxic to SH-SY5Y cells. All these effects were attenuated by pre-treatment with OBO. Prior treatment of SH-SY5Y cells with OBO also attenuated THP-1 or U373 conditioned media neurotoxicity and also reduced oxidative damage produced by treatment with hydrogen peroxide or BSO. Prior treatment with OBO potentiated survival of SH-SY5Y cells exposed to conditioned medium from BSO-treated THP-1, U373 cells, microglia and astrocytes. The data indicate that OBO could be anti-inflammatory, anti-oxidative and neuroprotective, and be an effective agent for inhibiting pathogenesis in neurological diseases such as Alzheimer disease, Parkinson disease and amyotrophic lateral sclerosis in which glial-mediated neuroinflammation and oxidative stress are thought to contribute to disease progression.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Kwon, Byoung Mog" sort="Kwon, Byoung Mog" uniqKey="Kwon B" first="Byoung-Mog" last="Kwon">Byoung-Mog Kwon</name>
<name sortKey="Kwon, Byoung Mok" sort="Kwon, Byoung Mok" uniqKey="Kwon B" first="Byoung-Mok" last="Kwon">Byoung-Mok Kwon</name>
<name sortKey="Lee, Moonhee" sort="Lee, Moonhee" uniqKey="Lee M" first="Moonhee" last="Lee">Moonhee Lee</name>
<name sortKey="Mcgeer, Edith" sort="Mcgeer, Edith" uniqKey="Mcgeer E" first="Edith" last="Mcgeer">Edith Mcgeer</name>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
<name sortKey="Suk, Kyoungho" sort="Suk, Kyoungho" uniqKey="Suk K" first="Kyoungho" last="Suk">Kyoungho Suk</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001244 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001244 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21796424
   |texte=   Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21796424" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022